Cardiology – Page 5

Evaluating Left Atrial Appendage Closure Versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: An Updated Meta-Analysis

By MedXY 10/05/2026

This meta-analysis consolidates data from six RCTs comparing left atrial appendage closure (LAAC) to oral anticoagulation for stroke prevention in atrial fibrillation, highlighting reduced bleeding with LAAC but increased ischemic stroke risk.

Cardiology Diabetes & Endocrinology news

Unveiling Cardiovascular Benefits of Tirzepatide: Insights from SURPASS-CVOT Using Imputed Placebo Analysis of REWIND

By MedXY 10/05/2026

An indirect comparison shows tirzepatide significantly reduces major adverse cardiovascular events and mortality in type 2 diabetes patients, highlighting its potential for improving cardiovascular outcomes.

Cardiology news

No-Touch Versus Conventional Vein Harvesting in Coronary Bypass Surgery: Insights from the SWEDEGRAFT Seven-Year Randomized Trial

By MedXY 10/05/2026

The SWEDEGRAFT trial reveals no significant difference in 7-year major clinical outcomes between no-touch and conventional saphenous vein harvesting in CABG, despite prior reports of improved graft patency but increased leg wound complications with no-touch technique.

Cardiology Clinical Updates news

Cardiovascular-Kidney-Metabolic Multimorbidity in Heart Failure: Prevalence, Prognostic Impact, and Clinical Implications Across Ejection Fraction Phenotypes

By MedXY 10/05/2026

Most heart failure patients harbor multiple cardiovascular-kidney-metabolic conditions, which independently escalate mortality and readmission risk, especially in HFrEF, underscoring the need for integrated management strategies tailored by ejection fraction.

Cardiology news Pathology & Lab Medicine

HEARTBiT: A Breakthrough Transcriptomic Biomarker for Early Detection of Acute Cellular Rejection Post-Heart Transplantation

By MedXY 10/04/2026

HEARTBiT, a novel transcriptomic biomarker, effectively detects moderate-to-severe acute cellular rejection within the first year after heart transplantation, offering a minimally invasive alternative to biopsy, especially during the high-risk early postoperative period.

Cardiology news

Bringing Cardiac MRI into Everyday Cardiology: Key Recommendations from the 2026 EHJ Consensus

By MedXY 10/04/2026

A practical, clinician-focused summary of the 2026 European Heart Journal consensus on implementing cardiac magnetic resonance (CMR) across common cardiac diseases, highlighting indications, protocols, prognostic use, device safety, and workflow integration.

Cardiology news

Secreted Modular Calcium-Binding Protein 1: A Novel Protective Factor to Prevent Cardiac Rupture Post-Acute Myocardial Infarction

By MedXY 10/04/2026

SMOC-1, secreted by cardiomyocytes after acute myocardial infarction, supports fibrosis and scar formation, reducing cardiac rupture risk. Enhancing this pathway offers promising therapeutic potential.

Cardiology Neurology news

Hospital Stroke Center Designation Influences Reported Stroke Rates After TAVR: Implications for Quality Assessment

By MedXY 10/04/2026

National data show that Comprehensive Stroke Center status and trial participation independently predict reported stroke rates after TAVR, highlighting potential ascertainment bias affecting hospital performance metrics.

Cardiology news Pathology & Lab Medicine/Bệnh học

Unraveling Abdominal Aortic Aneurysm: Epigenetic Links to Inflammation and Lipid Metabolism

By MedXY 10/04/2026

An epigenome-wide study reveals that DNA methylation markers linked to inflammatory pathways and blood lipid traits play a causal role in abdominal aortic aneurysm development, offering potential for improved risk prediction and therapeutic targeting.

Cardiology Diabetes & Endocrinology news

Reassessing Testosterone Therapy: Insights from Two Landmark Randomized Trials on Efficacy and Safety

By MedXY 10/01/2026

Two large randomized trials reveal that testosterone therapy improves sexual function and mood without increasing cardiovascular risks in men with age-related low testosterone, but does not enhance vitality or physical function.

$Lidocaine Versus Amiodarone for Refractory Ventricular Fibrillation in Adult In-Hospital Cardiac Arrest: Evidence from a Nationwide Chinese Registry$

Cardiology Critical Care news

Lidocaine Versus Amiodarone for Refractory Ventricular Fibrillation in Adult In-Hospital Cardiac Arrest: Evidence from a Nationwide Chinese Registry

By MedXY 09/30/2026

A nationwide prospective study shows no significant difference in survival or neurological outcomes between lidocaine and amiodarone for adult in-hospital cardiac arrest patients with refractory ventricular fibrillation or pulseless ventricular tachycardia.

Cardiology Diabetes & Endocrinology news

Unraveling the Predictors of Peak Weight Loss with Semaglutide in Cardiovascular Patients: Insights from the SELECT Trial

By MedXY 09/29/2026

In the SELECT trial, baseline clinical factors poorly predicted peak body weight loss with semaglutide, highlighting the role of sex and dosage but underscoring substantial unexplained variability in patient response.

Cardiology news Respiratory

Pulmonary Artery Dilation as a Mark of Pulmonary Hypertension in Chronic Lung Disease: Insights from the PVDOMICS Cohort

By MedXY 09/29/2026

Pulmonary artery dilation on chest CT correlates with pulmonary hypertension across chronic lung diseases, with diagnostic accuracy varying by disease subtype.

Cardiology Clinical Updates Diabetes & Endocrinology news

Diabetes Duration and Advanced Diabetes-Related Complications in Lower-Extremity Versus Coronary Revascularization: A Comparative Review

By MedXY 09/29/2026

This review synthesizes evidence comparing diabetes duration and advanced complications between patients undergoing revascularization for lower extremity artery disease (LEAD) and coronary artery disease (CAD), highlighting the heavier diabetes burden in LEAD patients despite similar glycemic control.

Cardiology news

Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

By MedXY 09/28/2026

A phase 2 clinical study demonstrates that lumacaftor safely shortens QTc in LQT2 patients with KCNH2 trafficking defects, supported by patient-specific cardiomyocyte models validating the mechanism.

Cardiology Diabetes & Endocrinology news

Unraveling the Cardiovascular Benefits of Semaglutide: Insights from the SELECT Trial Mediation Analysis

By MedXY 09/28/2026

The SELECT trial demonstrates semaglutide's 20% reduction in major cardiovascular events in adults with obesity and cardiovascular disease. Mediation analysis reveals partial but uncertain roles of weight, inflammation, and glycemic markers, highlighting the need for further mechanistic research.

Cardiology Internal Medicine news

Multidimensional Functional Decline Precedes Cardiovascular Events: Insights from the ASPREE Study

By MedXY 09/28/2026

Declines in frailty, intrinsic capacity, and physical quality of life occur years before cardiovascular events, highlighting a prolonged window for early intervention in older adults.

Cardiology Neurology news

Atrial Fibrillation Density: A Novel Biomarker Enhancing Ischaemic Stroke Risk Prediction

By MedXY 09/28/2026

Atrial fibrillation density, reflecting temporal episode clustering, independently predicts ischaemic stroke risk and improves risk stratification beyond traditional AF burden metrics, enabling more precise stroke prevention strategies.

Cardiology Clinical Updates news

Stroke and Systemic Embolism Following Atrial Fibrillation Ablation: Insights from the EMBOL-AF Global Registry and Contemporary Evidence

By MedXY 09/27/2026

The EMBOL-AF Global Registry provides comprehensive data on stroke and systemic embolism post-atrial fibrillation ablation, highlighting incidence, timing, risk factors, and procedural impacts alongside evolving ablation strategies and long-term cardiovascular outcomes.

Cardiology Internal Medicine news

Unraveling the Clinical Complexity of Extremely High NT-proBNP in Hospitalized Adults: Beyond Heart Failure

By MedXY 09/27/2026

Extremely high NT-proBNP levels in hospitalized patients often indicate infection rather than heart failure, with a high mortality risk; interpretation requires comprehensive clinical context.